3656 results for «335»
3656 results
Complication cases - Best case submissions
06 Dec 2023 – From GulfPCR-GIM 2023
Benefit from a selection of 6 clinical cases whose complications are particularly interesting to discuss, including pericardial effusion following circumflex artery intervention, or Rota burr incarceration, to perfect your knowledge and gain tips and tricks to manage them better when you, in turn, come up against...
How should I treat my female patients?
07 Dec 2023 – From GulfPCR-GIM 2023
This 100% all-female session, in every aspect, highlights the fact that female patients have a higher prevalence of SCAD and MINOCA, focuses on the advances in everyday technologies such as intracoronary imaging and intracoronary functional assessment that facilitate the establishment of a definitive diagnosis in many...
Five most impactful trials in 2023
02 Jan 2024 – From GulfPCR-GIM 2023
Find out how, based on an initial clinical situation, the scientific evidence gathered between January and December on the key subjects selected for 2023, focusing on coronary issues, might have had an impact on daily practice, or is encouraging changes in practice, from MVD in ACS...
Cracking new horizons across all calcium morphologies
07 Dec 2023 – From GulfPCR-GIM 2023
Watch this session to learn all about the intravascular lithotripsy (IVL) mechanism for treating calcified lesions. Discover practical advice and techniques for implementing IVL in challenging calcified lesions and the safe utilization of IVL in left main bifurcations.
Ultra-low contrast techniques in complex and high-risk coronary interventions
07 Dec 2023 – From GulfPCR-GIM 2023
Explore this session to gain insights into reducing operator reliance on contrast in PCI for enhanced safety and quality, particularly in complex scenarios. Discover essential tips, tricks, and specialized tools tailored for ultra-low-contrast PCI. Additionally, immerse yourself in a practical, step-by-step example through a recorded ultra-low-contrast...
Complex PCI in high bleeding risk patients, the way forward!
07 Dec 2023 – From GulfPCR-GIM 2023
Consult this session for insights on customizing PCI strategies for high-bleeding-risk patients, and selecting Drug-Eluting Stents in complex PCI. Additionally, examine the outcomes of the Ultimaster DES in high-bleeding-risk trials, particularly in the context of short Dual Antiplatelet Therapy.
Challenging structural interventions: part 1
06 Dec 2023 – From GulfPCR-GIM 2023
In these slides, explore a selection of cases focusing on challenging structural interventions, with a case of complex bicuspid aortic valve, and a special focus on TAVI dysfunction.
OCT-guided PCI for a patient with calcified lesion
07 Dec 2023 – From GulfPCR-GIM 2023
Consult this session to gain insights into the significance of actionable intracoronary imaging in the patient treatment journey and acquire knowledge on adopting procedural strategies. Learn about the effective utilisation of orbital atherectomy for plaque modification and the impact of DES platforms in the management of...
Legal notice
19 Oct 2018
Updated - August 22nd, 2023
AsiaPCR 2018: General Terms and conditions of sale
MASTER-DAPT: “the MASTER of high-bleeding risk trials”
28 Aug 2021
Marco Valgimigli (Lugano, Switzerland) presented the results of the MASTER DAPT trial on Saturday, August 28, in a Hot Line session of the ESC Congress 2021. Luis G. Ortega-Paz provides his PICOT & SWOT analysis of this study.
Author
ALL-RISE: A large-scale, global randomized trial of coronary physiology derived from conventional angiography compared with an invasive pressure wire-based approach to guide PCI
28 Mar 2026
Mirvat Al Asnag provides her take on the ALL-RISE randomised trial presented by Ajay J. Kirtane at ACC.26 in New Orleans.
Author
Europa Group's General Terms and Conditions of Sale
12 Apr 2024
Ref 02P - Updated June 2024
Harmonising optimal strategy for treatment of coronary artery diseases – bleeding risk: HOST-BR
29 Mar 2025
Daniele Giacoppo and Nicola Ammirabile provide their take on the main results of the HOST-BR trial, presented by Hyo-Soo Kim at ACC.25 in Chicago.
Author
Author
The AQUATIC trial: Assessment of quitting versus using aspirin therapy in patients with stabilized coronary artery disease after stenting who require long-term oral anticoagulation
01 Sep 2025
Chiara De Biase provides her take on the results of AQUATIC presented by Martine Gilard at ESC Congress 2025 in Madrid.
Author
![The AQUATIC trial [Assessment of quitting versus using aspirin therapy in patients with stabilized coronary artery disease after stenting who require long-term oral anticoagulation: Rationale for and design of the AQUATIC double-blind randomized trial]](https://www.pcronline.com/var/pcrov3/storage/images/pcronline/news/congress-coverages/esc/2025/aquatic-trial-quitting-versus-using-aspirin-therapy-patients-stabilized-cad-stenting-long-term-oral-anticoagulation/27448089-9-eng-GB/The-AQUATIC-trial-Assessment-of-quitting-versus-using-aspirin-therapy-in-patients-with-stabilized-coronary-artery-disease-after-stenting-who-requi_image_responsive_6.jpg)
NEO-MINDSET: Early withdrawal of aspirin after percutaneous coronary intervention for acute coronary syndrome
02 Sep 2025
Daniele Giacoppo reports and provides his perspective on the main results of the ambitious NEOMINDSET trial, presented by Pedro Lemos from the Hospital Israelita Albert Einstein, São Paulo, Brazil, during a Late Breaking Trials session at the ESC Congress 2025 in Madrid, and simultaneously published in the New...
Author
